Next Article in Journal
It’s More Than a Blood Test: Patients’ Perspectives on Noninvasive Prenatal Testing
Next Article in Special Issue
Roles of Sphingolipid Metabolism in Pancreatic β Cell Dysfunction Induced by Lipotoxicity
Previous Article in Journal / Special Issue
Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling
Article Menu

Export Article

Open AccessReview
J. Clin. Med. 2014, 3(2), 595-613; doi:10.3390/jcm3020595

Optimal Pharmacologic Treatment Strategies in Obesity and Type 2 Diabetes

1
North Bronx Healthcare Network, 3424 Kossuth Avenue, Bronx, NY 10467, USA
2
Touro College of Pharmacy, New York, NY 10027, USA
*
Author to whom correspondence should be addressed.
Received: 25 March 2014 / Revised: 28 April 2014 / Accepted: 20 May 2014 / Published: 18 June 2014
(This article belongs to the Special Issue Obesity, Diabetes and Metabolic Syndrome)
View Full-Text   |   Download PDF [485 KB, uploaded 20 June 2014]   |  

Abstract

The prevalence of obesity has increased to pandemic levels worldwide and is related to increased risk of morbidity and mortality. Metabolic comorbidities are commonly associated with obesity and include metabolic syndrome, pre-diabetes, and type 2 diabetes. Even if the prevalence of obesity remains stable until 2030, the anticipated numbers of people with diabetes will more than double as a consequence of population aging and urbanization. Weight reduction is integral in the prevention of diabetes among obese adults with pre-diabetes. Lifestyle intervention and weight reduction are also key in the management of type 2 diabetes. Weight loss is challenging for most obese patients, but for those with diabetes, it can pose an even greater challenge due to the weight gain associated with many treatment regimens. This article will review optimal treatment strategies for patients with comorbid obesity and type 2 diabetes. The role of anti-obesity agents in diabetes will also be reviewed. This literature review will provide readers with current strategies for the pharmacologic treatment of obesity and diabetes with a focus on the weight outcomes related to diabetes treatments. View Full-Text
Keywords: obesity; type 2 diabetes; obesity; obese diabetics; weight neutral diabetes medications; anti-obesity drugs; weight loss in diabetes obesity; type 2 diabetes; obesity; obese diabetics; weight neutral diabetes medications; anti-obesity drugs; weight loss in diabetes
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Goswami, G.; Shinkazh, N.; Davis, N. Optimal Pharmacologic Treatment Strategies in Obesity and Type 2 Diabetes. J. Clin. Med. 2014, 3, 595-613.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top